title: Second-line endocrine treatment of advanced breast cancer--a randomized cross-over study of medroxy-progesterone acetate and aminoglutethimide.
authors.affiliation: Department of Oncology, Sahlgrenska Hospital, Göteborg, Sweden.
authors.forename: R
authors.initials: R
authors.lastname: Hultborn
authors.forename: I
authors.initials: I
authors.lastname: Johansson-Terje
authors.forename: J
authors.initials: J
authors.lastname: Bergh
authors.forename: U
authors.initials: U
authors.lastname: Glas
authors.forename: L
authors.initials: L
authors.lastname: Hallsten
authors.forename: T
authors.initials: T
authors.lastname: Hatschek
authors.forename: E
authors.initials: E
authors.lastname: Holmberg
authors.forename: K
authors.initials: K
authors.lastname: Ideström
authors.forename: B
authors.initials: B
authors.lastname: Norberg
authors.forename: J
authors.initials: J
authors.lastname: Ranstam
authors.forename: M
authors.initials: M
authors.lastname: Söderberg
authors.forename: U B
authors.initials: UB
authors.lastname: Wallgren
mesh_terms: D000616:Aminoglutethimide / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D018592:Cross-Over Studies; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D045167:Progesterone Congeners / Q000627:therapeutic use*; D011788:Quality of Life
chemical_list: D018931:Antineoplastic Agents, Hormonal; D045167:Progesterone Congeners; D000616:Aminoglutethimide; D008525:Medroxyprogesterone